A devastating skin condition could soon get its first medication; the biotech scorecard for the second quarter

B-VEC — which is dripped onto wounds from a syringe — would be the first topical gene therapy and the first for a skin condition.

April 3, 2023 Check out STAT+

Sponsored By

Constanza Hevia for STAT STAT+ | A devastating skin condition could soon get its first medication, as the frontiers of gene therapy expand Approval is expected for a novel treatment for epidermolysis bullosa, or EB, a genetic condition that causes dangerously fragile skin. By Andrew Joseph STAT+ | The biotech scorecard for the second quarter: 24 stock-moving events to watch What to watch in Q2, including an advisory committee for Sarepta Therapeutics, results from Immunogen, and readouts from Fibrogen. By Adam Feuerstein STAT+ | FTC tells Illumina to divest Grail, boosting Icahn's case The agency said the $7.1 billion acquisition "would stifle competition and innovation in the U.S. market for life-saving cancer tests." By Matthew Herper Adobe Opinion: Emergency rooms need clear guidelines about how to handle law enforcement The ubiquity of law enforcement presence in emergency rooms is a major health equity issue impacting patient care, privacy, and trust. By Sally Mahmoud-Werthmann 'If we don't, others will': White House Covid adviser calls on doctors to combat a vacuum of medical information The coordinator of the White House Covid response team called on doctors to take a leadership role in battling medical misinformation. By Elizabeth Cooney STAT+ | Vertex, CRISPR Therapeutics inch ahead of rival for genetic fix to sickle cell disease The first CRISPR treatment for sickle cell disease has been submitted to the FDA, beating a rival gene therapy. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser